Evidence map›Paper›PMID 33805263›Full record

ArticleNutrients2021

COVID-19 Infection-Related Weight Loss Decreases Eating/Swallowing Function in Schizophrenic Patients.

Takeshi Kikutani, Yoko Ichikawa, Eri Kitazume, Arato Mizukoshi, Takashi Tohara, Noriaki Takahashi, Fumiyo Tamura, Manami Matsutani, Junko Onishi, Eiichiro Makino

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Takeshi KikutaniDivision of Clinical Oral Rehabilitation, Graduate School of Life Dentistry, The Nippon Dental University, Tokyo 184-0011, Japan.ORCID 0000-0003-3815-5545
Yoko IchikawaTama Oral Rehabilitation Clinic, The Nippon Dental University School of Life Dentistry, Tokyo 184-0011, Japan.
Eri KitazumeDepartment of Oral and Maxillofacial Surgery, The Nippon Dental University Hospital, Tokyo 102-8158, Japan.
Arato MizukoshiTama Oral Rehabilitation Clinic, The Nippon Dental University School of Life Dentistry, Tokyo 184-0011, Japan.
Takashi ToharaTama Oral Rehabilitation Clinic, The Nippon Dental University School of Life Dentistry, Tokyo 184-0011, Japan.
Noriaki TakahashiTama Oral Rehabilitation Clinic, The Nippon Dental University School of Life Dentistry, Tokyo 184-0011, Japan.
Fumiyo TamuraTama Oral Rehabilitation Clinic, The Nippon Dental University School of Life Dentistry, Tokyo 184-0011, Japan.
Manami MatsutaniMusashino Central Hospital, Tokyo 184-8585, Japan.
Junko OnishiMusashino Central Hospital, Tokyo 184-8585, Japan.
Eiichiro MakinoMusashino Central Hospital, Tokyo 184-8585, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn older people with psychoneurological diseases, COVID-19 infection may be associated with a risk of developing or exacerbating dysphagia. The aim of the present study was to examine the relationship between eating/swallowing function and COVID-19 infection.

methodsSubjects were 44 inpatients with confirmed COVID-19 infection being treated for schizophrenia in a psychiatric ward. Eating function was assessed using the Food Intake Level Scale (FILS) before and after infection. We also evaluated age, comorbidities, COVID-19 hospital stay, obesity index, weight loss rate, and chlorpromazine equivalent.

resultsSubjects had a mean age of 68.86 years. Pre-infection, 20 subjects had a FILS score of 7-9 (presence of eating/swallowing disorder) and 24 subjects had a score of 10 (normal). Eating function after infection resolution showed decreasing FILS score compared to that before infection in 14 subjects (74.14 years). Six subjects (79.3 years) transitioned from oral feeding to parenteral feeding. A ≥ 10% weight loss during infection treatment was significantly associated with decreased eating function and a transition to parenteral feeding. Chlorpromazine equivalents, comorbidities, and number of days of hospitalization showed no associations with decreased eating function.

conclusionsPreventing malnutrition during treatment for COVID-19 infection is important for improving post-infection life prognosis and maintaining quality of life (QOL).

Indexed as

Weight LossAgedCOVID-19Deglutition DisordersEatingFeeding and Eating DisordersFemaleHumansMaleMiddle AgedNutritional StatusSchizophreniacachexiaCOVID-19dysphagiaschizophreniaweight loss

Identifiers

PMID33805263
PMCPMC8065805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.